AZ-3102

· Azafaros A.G.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZ-3102, covering 2025-03-20 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZ-3102 in Patients with GM2 Gangliosidosis or Niemann-Pick Type C Disease [Phase 2]

See pricing